InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Stanislas Veillet, 董事长兼首席执行官. Director active across 1 company, notably BIOPHYTIS. In total, 5 reports have been recorded. Split: 1 buy · 2 sells. Total volume traded: €1.1m. History available since 7 June 2021. The latest transaction was disclosed on 5 March 2024 (Souscription). Regulator: AMF. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Stanislas Veillet is the Chairman & Chief Executive Officer of Biophytis, an innovative company in the biotechnology field. He leads the company's research and development efforts, focused on creating treatments for age-related diseases. With deep expertise in the sector, he plays a key role in the strategy and vision of Biophytis.